Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1256P (RNA, U6 small nuclear 1256, pseudogene) is a non-coding RNA pseudogene in the human genome. It is homologous to U6 small nuclear RNA (snRNA), a crucial component of the spliceosomal machinery, but RNU6-1256P itself does not produce functional RNA or protein. Unlike functional U6 snRNA genes, which are highly conserved and allow for proper pre-mRNA splicing, this pseudogene is classified as non-functional due to mutations, truncation, or lack of expression. There is no evidence to date indicating a direct biological function, disease association, or actionable therapeutic role for RNU6-1256P[4][5]. U6 snRNA is vital for splicing of pre-mRNA, but the genome contains many non-functional, pseudogenic copies like RNU6-1256P[1]. Pseudogenes in general can sometimes influence gene expression by acting as decoys or sponges for regulatory molecules (such as microRNAs), but this property is context- and gene-specific and is not demonstrated for RNU6-1256P[6]. Major biological databases (GeneCards, NCBI, Ensembl, BioGPS) list no function, protein products, or disease relevance for RNU6-1256P[4][5].
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1256, pseudogene (RNU6-1256P).